Compare · HIMS vs OMDA
HIMS vs OMDA
Side-by-side comparison of Hims & Hers Health Inc. (HIMS) and Omada Health Inc. (OMDA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HIMS and OMDA operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS is the larger of the two at $6.29B, about 5.9x OMDA ($1.06B).
- Over the past year, HIMS is down 52.2% and OMDA is down 21.1% - OMDA leads by 31.1 points.
- HIMS has been more active in the news (20 items in the past 4 weeks vs 5 for OMDA).
- HIMS has more recent analyst coverage (25 ratings vs 11 for OMDA).
- Company
- Hims & Hers Health Inc.
- Omada Health Inc.
- Price
- $27.18+3.76%
- $17.88-0.22%
- Market cap
- $6.29B
- $1.06B
- 1M return
- +5.88%
- +8.96%
- 1Y return
- -52.20%
- -21.06%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- 2025
- News (4w)
- 20
- 5
- Recent ratings
- 25
- 11
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest HIMS
- Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims
- Hims & Hers Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits
- Hims & Hers Completes Acquisition of Eucalyptus, Accelerating Its Push to Transform Healthcare for Canadians
- Hims & Hers Completes Acquisition of Eucalyptus, Expanding Access to Comprehensive, Clinically-Backed Weight Management Care in Germany
- Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World's Largest Consumer Health Platform
- Hims & Hers Completes Acquisition of Eucalyptus, Parent Company of Juniper, Officially Entering Japanese Market
- Hims & Hers Completes Acquisition of Eucalyptus, Advancing Position as the World's Largest Consumer Health Platform
- Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners
- Director Wells David B bought $1,172,974 worth of shares (48,400 units at $24.23), increasing direct ownership by 27% to 224,417 units (SEC Form 4)
- SEC Form 4 filed by Chief Medical Officer Carroll Patrick Harrison
Latest OMDA
- Chief Financial Officer Cook Steven L. covered exercise/tax liability with 4,493 shares, decreasing direct ownership by 2% to 196,019 units (SEC Form 4)
- Chief Accounting Officer Gracey Craig covered exercise/tax liability with 385 shares, decreasing direct ownership by 2% to 16,085 units (SEC Form 4)
- President Shao Wei-Li covered exercise/tax liability with 6,180 shares, decreasing direct ownership by 2% to 322,670 units (SEC Form 4)
- Chief Executive Officer Duffy Sean P. covered exercise/tax liability with 9,884 shares, decreasing direct ownership by 2% to 440,693 units (SEC Form 4)
- Omada Health to Participate in Goldman Sachs Global Healthcare Conference
- Amendment: SEC Form SCHEDULE 13G/A filed by Omada Health Inc.
- SEC Form 10-Q filed by Omada Health Inc.
- Omada Health Joins Lilly Employer Connect, Expanding Its Access Pathways for GLP-1 Care as Patients Seek More Lifestyle Support
- Omada Health Reports First Quarter 2026 Results
- Omada Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits